As of 2025-09-16, the Relative Valuation of Maravai LifeSciences Holdings Inc (MRVI) is (19.37) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.72 USD, the upside of Maravai LifeSciences Holdings Inc based on Relative Valuation is -812.1%.
The range of the Relative Valuation is (19.34) - (18.94) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 25.4x - 28.4x | 26.6x |
| Forward P/E multiples | 24.0x - 24.8x | 24.2x |
| Fair Price | (19.34) - (18.94) | (19.37) |
| Upside | -810.9% - -796.4% | -812.1% |
| Date | P/E |
| 2025-09-15 | -3.57 |
| 2025-09-12 | -3.50 |
| 2025-09-11 | -3.66 |
| 2025-09-10 | -3.41 |
| 2025-09-09 | -3.49 |
| 2025-09-08 | -3.20 |
| 2025-09-05 | -3.29 |
| 2025-09-04 | -3.09 |
| 2025-09-03 | -3.09 |
| 2025-09-02 | -3.11 |
| 2025-08-29 | -3.17 |
| 2025-08-28 | -3.12 |
| 2025-08-27 | -3.06 |
| 2025-08-26 | -3.17 |
| 2025-08-25 | -3.15 |
| 2025-08-22 | -3.21 |
| 2025-08-21 | -3.13 |
| 2025-08-20 | -3.23 |
| 2025-08-19 | -3.29 |
| 2025-08-18 | -3.37 |
| 2025-08-15 | -3.42 |
| 2025-08-14 | -3.41 |
| 2025-08-13 | -3.61 |
| 2025-08-12 | -3.53 |
| 2025-08-11 | -2.70 |
| 2025-08-08 | -2.89 |
| 2025-08-07 | -2.66 |
| 2025-08-06 | -2.67 |
| 2025-08-05 | -3.07 |
| 2025-08-04 | -2.98 |
| 2025-08-01 | -2.91 |
| 2025-07-31 | -3.07 |
| 2025-07-30 | -3.16 |
| 2025-07-29 | -3.25 |
| 2025-07-28 | -3.48 |
| 2025-07-25 | -3.53 |
| 2025-07-24 | -3.55 |
| 2025-07-23 | -3.44 |
| 2025-07-22 | -3.32 |
| 2025-07-21 | -3.12 |
| 2025-07-18 | -3.19 |
| 2025-07-17 | -3.29 |
| 2025-07-16 | -3.30 |
| 2025-07-15 | -3.40 |
| 2025-07-14 | -3.50 |
| 2025-07-11 | -3.58 |
| 2025-07-10 | -3.79 |
| 2025-07-09 | -3.62 |
| 2025-07-08 | -3.62 |
| 2025-07-07 | -3.41 |